The Affiliated Hospital of Guangzhou Medical College, Guangzhou, China.
China-Japan Friendship Hospital, Beijing 100029, China.
Bone Joint Res. 2015 Apr;4(4):56-64. doi: 10.1302/2046-3758.44.2000310.
The major problem with repair of an articular cartilage injury is the extensive difference in the structure and function of regenerated, compared with normal cartilage. Our work investigates the feasibility of repairing articular osteochondral defects in the canine knee joint using a composite lamellar scaffold of nano-ß-tricalcium phosphate (ß-TCP)/collagen (col) I and II with bone marrow stromal stem cells (BMSCs) and assesses its biological compatibility.
The bone-cartilage scaffold was prepared as a laminated composite, using hydroxyapatite nanoparticles (nano-HAP)/collagen I/copolymer of polylactic acid-hydroxyacetic acid as the bony scaffold, and sodium hyaluronate/poly(lactic-co-glycolic acid) as the cartilaginous scaffold. Ten-to 12-month-old hybrid canines were randomly divided into an experimental group and a control group. BMSCs were obtained from the iliac crest of each animal, and only those of the third generation were used in experiments. An articular osteochondral defect was created in the right knee of dogs in both groups. Those in the experimental group were treated by implanting the composites consisting of the lamellar scaffold of ß-TCP/col I/col II/BMSCs. Those in the control group were left untreated.
After 12 weeks of implantation, defects in the experimental group were filled with white semi-translucent tissue, protruding slightly over the peripheral cartilage surface. After 24 weeks, the defect space in the experimental group was filled with new cartilage tissues, finely integrated into surrounding normal cartilage. The lamellar scaffold of ß-TCP/col I/col II was gradually degraded and absorbed, while new cartilage tissue formed. In the control group, the defects were not repaired.
This method can be used as a suitable scaffold material for the tissue-engineered repair of articular cartilage defects. Cite this article: Bone Joint Res 2015;4:56-64.
关节软骨损伤修复的主要问题是,与正常软骨相比,再生软骨在结构和功能上存在广泛差异。我们的工作是研究使用纳米 β-磷酸三钙(β-TCP)/I 型和 II 型胶原(col)复合层状支架与骨髓基质干细胞(BMSCs)修复犬膝关节关节骨软骨缺损的可行性,并评估其生物相容性。
使用纳米羟基磷灰石(nano-HAP)/I 型胶原/聚乳酸-羟基乙酸共聚物作为骨支架,透明质酸钠/聚(乳酸-共-乙醇酸)作为软骨支架,制备骨-软骨支架的层状复合材料。将 10-12 月龄杂种犬随机分为实验组和对照组。从每只动物的髂嵴获取 BMSCs,仅使用第三代细胞进行实验。在两组犬的右膝关节均创建关节骨软骨缺损。实验组植入由 β-TCP/col I/col II/BMSCs 层状支架复合材料组成的植入物。对照组不做任何处理。
植入后 12 周,实验组缺损部位填充了白色半透明组织,略微突出于周围软骨表面。24 周后,实验组的缺损空间被新的软骨组织填充,与周围正常软骨精细整合。β-TCP/col I/col II 层状支架逐渐降解和吸收,同时形成新的软骨组织。对照组,缺损未修复。
该方法可作为组织工程修复关节软骨缺损的合适支架材料。